Intraday BUY SELL Signals
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
EFAV vs GSK
EFAV vs GSK Comparison
Open Charts EFAV vs GSK
iShares MSCI EAFE Min Vol Factor ETF
Price$87.63
Change+$0.71 (+0.82%)
Volume$494.8K
Net Assets5.26B
EFAV vs GSK Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
EFAV vs. GSK commentary
Jan 15, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFAV is a Hold and GSK is a Hold.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 38 | |
SMR RATING 1..100 | 25 | |
PRICE GROWTH RATING 1..100 | 42 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | 23 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 67% | N/A |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 44% |
| Momentum ODDS (%) | N/A | 3 days ago 61% |
| MACD ODDS (%) | 3 days ago 73% | 3 days ago 67% |
| TrendWeek ODDS (%) | 3 days ago 77% | 3 days ago 49% |
| TrendMonth ODDS (%) | 3 days ago 73% | 3 days ago 59% |
| Advances ODDS (%) | 4 days ago 75% | 9 days ago 61% |
| Declines ODDS (%) | 9 days ago 75% | 29 days ago 51% |
| BollingerBands ODDS (%) | 3 days ago 76% | 3 days ago 41% |
| Aroon ODDS (%) | 3 days ago 74% | 3 days ago 53% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
EFAV and
Correlation & Price change
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with TEF. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then TEF could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | +0.82% | ||
| TEF - EFAV | 57% Loosely correlated | +2.36% | ||
| GSK - EFAV | 56% Loosely correlated | +1.78% | ||
| HLN - EFAV | 56% Loosely correlated | +1.32% | ||
| SAN - EFAV | 55% Loosely correlated | +0.25% | ||
| AZN - EFAV | 55% Loosely correlated | +1.94% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y